Two Sigma Securities, LLC Editas Medicine, Inc. Call Options Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$39.71 - $90.58 $520,201 - $1.19 Million	-13,100 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $354,617 - $1.1 Million	13,100 New	13,100 $918,000
Q1 2020 May 15, 2020	SELL	$14.88 - $32.78 $241,056 - $531,036	-16,200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.49 - $32.63 $315,738 - $528,606	16,200 New	16,200 $480,000
Q3 2019 Nov 14, 2019	SELL	$22.49 - $26.81 $676,949 - $806,981	-30,100 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$20.48 - $27.76 $350,208 - $474,696	17,100 Added 131.54%	30,100 $745,000
Q1 2019 May 15, 2019	BUY	$19.43 - $26.41 $252,590 - $343,330	13,000 New	13,000 $318,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.